CG Oncology (CGON) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CGON Stock Alerts $29.73 -0.25 (-0.83%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 5:52 PM | marketbeat.comCG Oncology (NASDAQ:CGON) Trading Down 3.9%CG Oncology (NASDAQ:CGON) Trading Down 3.9%May 16, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Trading Up 9.8%CG Oncology (NASDAQ:CGON) Shares Up 9.8%May 15, 2024 | americanbankingnews.comCG Oncology (NASDAQ:CGON) Upgraded to "Buy" by The Goldman Sachs GroupMay 14, 2024 | markets.businessinsider.comDecoding 10 Analyst Evaluations For CG OncologyMay 14, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Gap Up to $25.84CG Oncology (NASDAQ:CGON) Shares Gap Up to $25.84May 14, 2024 | msn.comGoldman Sachs Upgrades CG Oncology (CGON)May 13, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Stock Rating Upgraded by The Goldman Sachs GroupThe Goldman Sachs Group raised shares of CG Oncology from a "neutral" rating to a "buy" rating and set a $50.00 price target on the stock in a report on Monday.May 12, 2024 | americanbankingnews.comCG Oncology (NASDAQ:CGON) Hits New 12-Month Low at $28.52May 10, 2024 | markets.businessinsider.comBuy Rating for CG Oncology on Strong Trial Results and Market PotentialMay 10, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Hits New 1-Year Low at $28.52CG Oncology (NASDAQ:CGON) Sets New 1-Year Low at $28.52May 9, 2024 | globenewswire.comCG Oncology Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 8, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Trading Down 8.1%CG Oncology (NASDAQ:CGON) Shares Down 8.1%May 6, 2024 | markets.businessinsider.comCG Oncology’s Cretostimogene Shows Promising Efficacy and Safety in NMIBC Treatment, Merits Buy RatingMay 6, 2024 | seekingalpha.comCG Oncology: ASCO Play And Top-Line Data End Of 2024 Could Drive Further ValueMay 6, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $75.00 target price on shares of CG Oncology in a research note on Monday.May 4, 2024 | markets.businessinsider.comBuy Rating Justified by CG Oncology’s Cretosmogene Efficacy and Market PositioningMay 3, 2024 | seekingalpha.comCG Oncology reports data from Phase 3 bladder cancer studyMay 3, 2024 | seekingalpha.comCG Oncology's Promising Bladder Cancer Treatment: Balancing Hope And Risk In Late-Stage TrialsMay 3, 2024 | globenewswire.comCretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder CancerMay 2, 2024 | marketbeat.comCG Oncology's (CGON) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $75.00 price objective on shares of CG Oncology in a research note on Thursday.April 26, 2024 | globenewswire.comCG Oncology to Host Virtual Investor Event on Friday, May 3, 2024April 25, 2024 | marketbeat.comFY2024 EPS Estimates for CG Oncology, Inc. Cut by Analyst (NASDAQ:CGON)CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at Lifesci Capital dropped their FY2024 earnings per share (EPS) estimates for shares of CG Oncology in a research note issued on Tuesday, April 23rd. Lifesci Capital analyst S. Slutsky now anticipates that the company wilApril 24, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - CGONApril 24, 2024 | globenewswire.comCG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024April 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for CG Oncology Amidst Bladder Cancer Treatment Landscape and BCG ShortageApril 23, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Up 7.9%CG Oncology (NASDAQ:CGON) Trading 7.9% HigherApril 16, 2024 | finance.yahoo.comCG Oncology, Inc. (CGON)April 15, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Stock Price Down 6%CG Oncology (NASDAQ:CGON) Trading Down 6%April 12, 2024 | msn.com20 Countries with the Most Domestically Listed Companies in the WorldApril 8, 2024 | marketbeat.comEquities Analysts Set Expectations for CG Oncology, Inc.'s FY2024 Earnings (NASDAQ:CGON)CG Oncology, Inc. (NASDAQ:CGON - Free Report) - Stock analysts at HC Wainwright lifted their FY2024 earnings estimates for CG Oncology in a research report issued on Thursday, April 4th. HC Wainwright analyst A. Maldonado now forecasts that the company will post earnings per share of ($2.00) forApril 5, 2024 | marketbeat.comFY2028 EPS Estimates for CG Oncology, Inc. (NASDAQ:CGON) Raised by AnalystCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Equities research analysts at HC Wainwright upped their FY2028 earnings per share estimates for CG Oncology in a report released on Thursday, April 4th. HC Wainwright analyst A. Maldonado now expects that the company will post earnings of $1.45 perApril 5, 2024 | investing.comCG Oncology Inc (CGON)April 5, 2024 | markets.businessinsider.comBuy Rating Affirmed for CG Oncology on Strong Clinical Data and Market PotentialApril 4, 2024 | marketbeat.comCG Oncology's (CGON) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $75.00 price target on shares of CG Oncology in a research report on Thursday.April 3, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Stock Price Down 5.1%CG Oncology (NASDAQ:CGON) Trading Down 5.1%April 3, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Stock Price Down 5.1%CG Oncology (NASDAQ:CGON) Trading Down 5.1%April 1, 2024 | markets.businessinsider.comBuy Rating Justified by CG Oncology’s Strong Clinical Trial Results and Promising Cretosimogene TherapyMarch 28, 2024 | globenewswire.comCG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual MeetingMarch 20, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Gap Down to $39.70CG Oncology (NASDAQ:CGON) Shares Gap Down to $39.70March 19, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Stock Price Up 7.1%CG Oncology (NASDAQ:CGON) Stock Price Up 7.1%March 13, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Trading Up 7.1%CG Oncology (NASDAQ:CGON) Trading 7.1% HigherMarch 1, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Down 3.9% CG Oncology (NASDAQ:CGON) Shares Down 3.9%March 1, 2024 | seekingalpha.comCGON CG Oncology, Inc.February 28, 2024 | markets.businessinsider.comBuy Rating Affirmed for CG Oncology, Inc. on Promising CG0070 Phase 3 Trials and Unmet Medical NeedFebruary 27, 2024 | finance.yahoo.comCG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder CancerFebruary 23, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Shares Down 7% CG Oncology (NASDAQ:CGON) Shares Down 7%February 23, 2024 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) to Post FY2023 Earnings of ($1.23) Per Share, Cantor Fitzgerald ForecastsCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2023 EPS estimates for CG Oncology in a research note issued to investors on Tuesday, February 20th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings of ($1.23)February 20, 2024 | msn.comCantor starts CG Oncology at overweight, cites bladder cancer treatmentFebruary 20, 2024 | realmoney.thestreet.comCG Oncology initiated with neutral view at Goldman Sachs, here's whyFebruary 20, 2024 | realmoney.thestreet.comCG Oncology initiated with bullish view at Morgan Stanley, here's why Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. CGON Media Mentions By Week CGON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼0.430.42▲Average Medical News Sentiment CGON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼84▲CGON Articles Average Week Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fusion Pharmaceuticals News Today Ginkgo Bioworks News Today Novavax News Today Inhibrx News Today Beam Therapeutics News Today Sana Biotechnology News Today ADMA Biologics News Today Neumora Therapeutics News Today Kymera Therapeutics News Today Tarsus Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
